Skip to main content

Actemra ACTPen

NDC 50242-143 · Genentech, Inc.

Generic nametocilizumab
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TOCILIZUMAB
Strength162 mg/.9mL
Pharmacologic classInterleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
Marketing categoryBLA

Packages

50242-143-01 — 1 SYRINGE, GLASS in 1 BOX (50242-143-01) / .9 mL in 1 SYRINGE, GLASS

50242-143-86 — 1 SYRINGE, GLASS in 1 BOX (50242-143-86) / .9 mL in 1 SYRINGE, GLASS

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50242-135 — tocilizumab, 50242-136 — tocilizumab, 50242-137 — tocilizumab, 50242-138 — tocilizumab, 64406-022 — Tocilizumab, 64406-023 — Tocilizumab, 64406-024 — Tocilizumab, 65219-584 — Tocilizumab-aazg, 65219-586 — Tocilizumab-aazg, 65219-590 — Tocilizumab-aazg, 65219-592 — Tocilizumab-aazg, 65219-594 — Tocilizumab-aazg, 65219-596 — Tocilizumab-aazg, 65219-598 — Tocilizumab-aazg, 72606-042 — tocilizumab, 72606-043 — tocilizumab, 72606-044 — tocilizumab, 72606-045 — tocilizumab, 78206-200 — TOCILIZUMAB, 78206-201 — TOCILIZUMAB, +1 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.